Liver Cancer
Copyright ©The Author(s) 2003.
World J Gastroenterol. Sep 15, 2003; 9(9): 1940-1945
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.1940
Table 1 Inhibitory effect of pCH510 on murine tumor inoculated with different doses of tumor cells
Inoculative dosesnDissecting time (d)Tumor weight (g, -x±s)
ControlpCH510
1048212.19 ± 0.350a
1058142.27 ± 0.380.62 ± 0.17a
1068102.32 ± 0.421.35 ± 0.24a
107872.37 ± 0.331.88 ± 0.32b
Table 2 Inhibitory effect of pCH510 in combination with chemotherapy on murine tumor
GroupsnTumor weight (g, -x±s)
d 11d 21
A: control82.12 ± 0.38
B: pCH510 (d 2 to d11)80.82 ± 0.21 a
C: chemo I80 a
D: chemo II81.58 ± 0.31
E: MMC + pCH510 (d 2 to d 11)81.49 ± 0.28
F: MMC + pCH510 (d 6 to d 20)80.42 ± 0.12b
Table 3 Effects of MMC on activity of macrophages
Groupsn4 h
24 h
Metabolism OD570, (-x±s)NO mol/L, (-x±s)Metabolism OD570, (-x±s)NO mol/L, (-x±s)
Control60.35 ± 0.0629.9 ± 5.10.32 ± 0.0428.8 ± 6.3
MMC60.15 ± 0.03a16.5 ± 4.3a0.16 ± 0.04a13.9 ± 5.4a
Table 4 Inhibitory effect of pCH510 + Hsp70-H22 antigen peptide complex on murine tumor
Groupn105 H22 cells inoculation
106 H22 cells inoculation
Dissecting time (d)Tumor weight (g, -x±s)Dissecting time (d)Tumor weight (g, -x±s)
Control8143.24 ± 1.22103.45 ± 1.31
pCH510 plasmid8212.38 ± 0.84212.72 ± 1.28
Hsp70-H22 peptide8211.44 ± 0.45212.58 ± 0.93
Hsp70-H22 peptide + pCH5108210b211.76 ± 0.66a
Table 5 Inhibitory effect of chemotherapy + pCH510 + Hsp70-H22 peptide on murine tumor
GroupnH22 cell inoculatingDissecting time (d)Tumor weight (g, -x±s)
Control8106103.28 ± 1.12
MMC8106152.82 ± 0.94
MMC + pCH5108106301.51 ± 0.53
MMC + Hsp70-H22 peptide8106300.62 ± 0.22b
MMC + pCH510 + Hsp70-H22 peptide8106400a